Hindustan Laboratories Files IPO Papers to Fund Working Capital
Business
M
Moneycontrol•04-01-2026, 06:50
Hindustan Laboratories Files IPO Papers to Fund Working Capital
- •Generic drugmaker Hindustan Laboratories filed draft IPO papers with SEBI to raise funds.
- •The IPO comprises a fresh issue of 50 lakh shares and an OFS of 91 lakh shares by promoter Rajesh Vasantray Doshi.
- •Funds from the fresh issue, specifically Rs 72.5 crore, will be used for working capital requirements.
- •The company, incorporated in 2017, supplies 948 generic products to government institutions under a B2G model.
- •Reported FY2025 profit of Rs 41.3 crore (up 21%) and revenue of Rs 219.7 crore (up 17.9%).
Why It Matters: Hindustan Laboratories seeks IPO funds for working capital, leveraging its B2G generic drug model.
✦
More like this
Loading more articles...
